Effective Genetic Vaccination With a Widely Shared Endogenous Retroviral Tumor Antigen Requires CD40 Stimulation During Tumor Rejection Phase

Journal of Immunology - United States
doi 10.4049/jimmunol.171.12.6396
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

Identification of a Human Melanoma Antigen Recognized by Tumor-Infiltrating Lymphocytes Associated With in Vivo Tumor Rejection.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1994English

Human Papillomavirus Type 16 Nucleoprotein E7 Is a Tumor Rejection Antigen.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1991English

Whole Tumor Antigen Vaccination Using Dendritic Cells: Comparison of RNA Electroporation and Pulsing With UV-irradiated Tumor Cells

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2008English

Fas Ligand DNA Enhances a Vaccination Effect by Coadministered DNA Encoding a Tumor Antigen Through Augmenting Production of Antibody Against the Tumor Antigen

Journal of Immunology Research
MedicineAllergyImmunology
2015English

Effective Treatment of Established GL261 Murine Gliomas Through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+ T Cell Responses

PLoS ONE
Multidisciplinary
2015English

Impaired Tumor Antigen Processing by Immunoproteasome-Expressing CD40-activated B Cells and Dendritic Cells

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2011English

NF-κB Activation During Intradermal DNA Vaccination Is Essential for Eliciting Tumor Protective Antigen-Specific CTL Responses

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2013English

Vaccination With a Recombinant Saccharomyces Cerevisiae Expressing a Tumor Antigen Breaks Immune Tolerance and Elicits Therapeutic Antitumor Responses

Clinical Cancer Research
Cancer ResearchOncology
2008English

Off-The-Shelf Adenoviral-Mediated Immunotherapy via Bicistronic Expression of Tumor Antigen and iMyD88/CD40 Adjuvant

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy